-
ORIGINAL ARTICLE
Transgender people’s knowledge about the adverse effects of cross-hormonization: challenges for nursing
Revista Brasileira de Enfermagem. 2024;77(4):e20230346
09-20-2024
Resumo
ORIGINAL ARTICLETransgender people’s knowledge about the adverse effects of cross-hormonization: challenges for nursing
Revista Brasileira de Enfermagem. 2024;77(4):e20230346
09-20-2024DOI 10.1590/0034-7167-2023-0346
Visualizações0Ver maisABSTRACT
Objectives:
to identify trans women’s and men’s knowledge about the adverse effects of cross-hormonization and understand the repercussions of hormonization practices on trans women’s and men’s health.
Methods:
exploratory, descriptive, qualitative research, developed with 41 participants, from July 2019 to February 2020, in a trans health outpatient clinic. Thematic-categorical content analysis was used.
Results:
from the analysis, the categories emerged: Knowledge about the adverse effects of cross-hormonization; and Cross-hormonization practices and their meaning.
Final Considerations:
nursing practices, based on the identification of knowledge about adverse effects and the understanding of cross-hormonization practices in trans women’s and men’s health, can result in more inclusive care.
-
ORIGINAL ARTICLE
Risk factors for infiltration in children and adolescents with peripheral intravenous catheters
Revista Brasileira de Enfermagem. 2022;75(4):e20210176
04-15-2022
Resumo
ORIGINAL ARTICLERisk factors for infiltration in children and adolescents with peripheral intravenous catheters
Revista Brasileira de Enfermagem. 2022;75(4):e20210176
04-15-2022DOI 10.1590/0034-7167-2021-0176
Visualizações0ABSTRACT
Objectives:
to estimate the incidence of infiltration and the factors associated with its occurrence in children and adolescents in the operative period and with peripheral intravenous catheters.
Methods:
a longitudinal and prospective study with children and adolescents using peripheral intravenous catheters, conducted at the surgical clinic unit of a pediatric hospital in Feira de Santana, State of Bahia, from April 2015 to December 2016. The study used Pearson’s chi-square and Fisher’s exact test for the analysis. It also applied multiple analyses using Poisson regression with robust variance.
Results:
the incidence of infiltration was 31.2% and was associated with female sex (RR=0.53; CI=[0.30-0.96]), non-eutrophic children (RR=2.27; CI=[1.25-4.20]), who used non-irritating and non-vesicant drugs (RR=1.72; CI=[1.03-2.87]), vesicant drugs (RR=1.84; CI=[1.05-3.22]) and irritating/vesicant electrolytes (RR=2.35; CI=[1.38-3.97]).
Conclusions:
the study suggests the development of strategies that will help in the prevention of this adverse event through the knowledge of the associated factors.
Palavras-chave: Adverse EffectsCatheterizationsChild HospitalizationInfusionIntravenousPediatric NursingPeripheralVer mais -
ORIGINAL ARTICLE
Risk factors for site complications of intravenous therapy in children and adolescents with cancer
Revista Brasileira de Enfermagem. 2020;73(4):e20190471
06-08-2020
Resumo
ORIGINAL ARTICLERisk factors for site complications of intravenous therapy in children and adolescents with cancer
Revista Brasileira de Enfermagem. 2020;73(4):e20190471
06-08-2020DOI 10.1590/0034-7167-2019-0471
Visualizações0ABSTRACT
Objectives:
to analyze predictive factors for the incidence of complications related to peripheral venous catheters in children and adolescents with cancer.
Methods:
a longitudinal follow-up study, conducted at a pediatric oncology clinic unit of a hospital in Bahia, with 333 peripheral venous catheters inserted in 77 children and 26 adolescents. Data collection took place between April 2015 and December 2016 through direct observation of peripheral intravenous catheter insertion, medical record data collection and daily observation of the puncture site.
Results:
the incidence of complications was 18.6%. The modeling of the variables confirmed that the risk factors for complications in children/adolescents with cancer were: prolonged peripheral intravenous therapy (p=0.002), history of complications (p=0.000), non-irritating/vesicant medications (p=0.003) and vesicant solutions (p=0.000).
Conclusions:
the goal has been achieved. Results can contribute to the theoretical, practical and social context.
Palavras-chave: Adverse EffectsCatheterizations, PeripheralChild HospitalizationInfusion, IntravenousPediatric NursingVer mais -
REVISÃO
Cardiovascular adverse events associated with oral antineoplastic therapy
Revista Brasileira de Enfermagem. 2018;71(5):2561-2569
01-01-2018
Resumo
REVISÃOCardiovascular adverse events associated with oral antineoplastic therapy
Revista Brasileira de Enfermagem. 2018;71(5):2561-2569
01-01-2018DOI 10.1590/0034-7167-2017-0450
Visualizações0Ver maisABSTRACT
Objective:
To identify in the literature the cardiovascular adverse events resulting from oral antineoplastic therapy.
Method:
Integrative review of the literature through the SCOPUS, Scientific Electronic Library Online (SciELO), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Medical Literature Analysis and Retrieval System Online (MEDLINE) databases. The antineoplastic, cardiotoxicity, cardiovascular system and adverse reaction descriptors were used in Portuguese, English and Spanish. We selected 23 articles published between 1985 and 2015.
Results:
Twenty studies were related to cardiac events and eleven to peripheral vascular events. The most frequent adverse cardiac events were reduced left ventricular ejection fraction, myocardial infarction, changes in the electrocardiogram, heart failure and angina, whereas peripheral vascular events were hypertension and thromboembolism.
Conclusion:
Oral antineoplastic therapy is associated with different adverse events, including cardiac and peripheral vascular events.